Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Thompson

Showing results (131-140 of 692) with videos related to

Pageof 70
Sort By:
Surgical Oncology|July 22, 2008
The detection and significance of melanoma micrometastases in sentinel nodesRichard A Scolyer, Rajmohan Murali, Imke Satzger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2010
Non-Sentinel Node Risk Score (N-SNORE): a scoring system for accurately stratifying risk of non-sentinel node positivity in patients with cutaneous melanoma with positive sentinel lymph nodesRajmohan Murali, Chitra Desilva, John F Thompson, et al.
Clinical Nuclear Medicine|December 18, 2004
Minimally invasive radio-guided surgery for recurrent thyroid cancer using iodine-123Robert Mansberg, Bronwyn Crawford, Roger F Uren, et al.
Journal of Pediatric Gastroenterology and Nutrition|August 25, 2015
Normal Growth and Essential Fatty Acid Status in Children With Intestinal Failure on Lipid LimitationGillian Lam, Irina G Strogach, Nicole Baron, et al.
JAMA Dermatology|June 30, 2021
Characterizing the Clinical Implications of Histologic Regression in Melanoma Requires Clear Diagnostic Criteria That Are Consistently Applied-ReplyRichard A Scolyer, Mary-Ann El Sharouni, John F Thompson
Archives of Pathology & Laboratory Medicine|December 7, 2010
Histologically ambiguous ("borderline") primary cutaneous melanocytic tumors: approaches to patient management including the roles of molecular testing and sentinel lymph node biopsyRichard A Scolyer, Rajmohan Murali, Stanley W McCarthy, et al.
Scientific Reports|March 25, 2023
LNA blockers for improved amplification selectivityJaime Prout, Michael Tian, Alicia Palladino, et al.
Journal of Surgical Oncology|August 23, 2011
Ultrasound assessment of lymph nodes in the management of early-stage melanomaJohn F Thompson, Lauren E Haydu, Amira Sanki, et al.
Pathology|September 17, 2004
Spitz naevus: diagnostic problems and their management implicationsJane E Dahlstrom, Richard A Scolyer, John F Thompson, et al.
Annals of Surgical Oncology|March 13, 2002
Prognostic factors after isolated limb infusion with cytotoxic agents for melanomaPer Lindnér, Anna Doubrovsky, Peter C A Kam, et al.
Pageof 70

Showing results (131-140 of 692) with videos related to

Sort By:
Pageof 70
Surgical Oncology|July 22, 2008
The detection and significance of melanoma micrometastases in sentinel nodesRichard A Scolyer, Rajmohan Murali, Imke Satzger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2010
Non-Sentinel Node Risk Score (N-SNORE): a scoring system for accurately stratifying risk of non-sentinel node positivity in patients with cutaneous melanoma with positive sentinel lymph nodesRajmohan Murali, Chitra Desilva, John F Thompson, et al.
Clinical Nuclear Medicine|December 18, 2004
Minimally invasive radio-guided surgery for recurrent thyroid cancer using iodine-123Robert Mansberg, Bronwyn Crawford, Roger F Uren, et al.
Journal of Pediatric Gastroenterology and Nutrition|August 25, 2015
Normal Growth and Essential Fatty Acid Status in Children With Intestinal Failure on Lipid LimitationGillian Lam, Irina G Strogach, Nicole Baron, et al.
JAMA Dermatology|June 30, 2021
Characterizing the Clinical Implications of Histologic Regression in Melanoma Requires Clear Diagnostic Criteria That Are Consistently Applied-ReplyRichard A Scolyer, Mary-Ann El Sharouni, John F Thompson
Archives of Pathology & Laboratory Medicine|December 7, 2010
Histologically ambiguous ("borderline") primary cutaneous melanocytic tumors: approaches to patient management including the roles of molecular testing and sentinel lymph node biopsyRichard A Scolyer, Rajmohan Murali, Stanley W McCarthy, et al.
Scientific Reports|March 25, 2023
LNA blockers for improved amplification selectivityJaime Prout, Michael Tian, Alicia Palladino, et al.
Journal of Surgical Oncology|August 23, 2011
Ultrasound assessment of lymph nodes in the management of early-stage melanomaJohn F Thompson, Lauren E Haydu, Amira Sanki, et al.
Pathology|September 17, 2004
Spitz naevus: diagnostic problems and their management implicationsJane E Dahlstrom, Richard A Scolyer, John F Thompson, et al.
Annals of Surgical Oncology|March 13, 2002
Prognostic factors after isolated limb infusion with cytotoxic agents for melanomaPer Lindnér, Anna Doubrovsky, Peter C A Kam, et al.
Pageof 70